REGENXBIO

At our recent all company meeting, we announced our President’s Award winner, Matt Stone! Matt’s focus on the patients we serve allows him to lead our Clinical Supply teams with remarkable innovation and efficiency. Join us in congratulating Matt for this well-deserved recognition!

Last week at our all company meeting, we welcomed Sheryl Marrazzo, a dedicated Duchenne mother, advocate, and Community Outreach Coordinator at CureDuchenne. Sheryl shared her family’s powerful story and how they choose to live life to the fullest, even in the face of challenges. Thank you, Sheryl, for joining us and for inspiring us all! 

October is Blindness Awareness Month. At REGENXBIO, we are dedicated to developing gene therapies that have the potential to transform how vision-threatening diseases like wet AMD and diabetic retinopathy are treated. Let’s continue to advocate for vision health. #BlindnessAwarenessMonth

This Hispanic Heritage Month, we are proud to spotlight our incredible team members making their mark in #STEM. Hear from Leiby Soto, our amazing Administrative Assistant and Receptionist, about how she brings her perspective and culture to REGENXBIO. #HispanicHeritageMonth

REGENXBIO will participate in Chardan’s 8th Annual Genetic Medicines Conference. Learn more: https://lnkd.in/enPcs_R3

At REGENXBIO, we often talk about how “what we do matters” - to patients, to their families, and to their communities. Hear from Selase Enuameh, Sr. Scientist, Cell Line Development, as he reflects on what that means to him.

As we advance our pipeline of next-generation gene therapies towards commercialization, we are excited to welcome Mitchell Chan as EVP and Chief Financial Officer, succeeding Vit Vasista. We are grateful to Vit for his dedication and significant contributions to REGENXBIO over the last 15 years. Learn more about today's announcement and Mitchell's extensive financial leadership in biotechnology: https://lnkd.in/emKTnfVh

Yesterday was the start of Hispanic Heritage Month, a month-long celebration of Hispanic and Latino history and culture. Join us this month as we honor the contributions of some of our Hispanic and Latino team members who are advancing our mission to deliver new gene therapies to patients in need. You can learn more about Hispanic Heritage Month here: https://lnkd.in/draRs_4h

We’re proud of our collaborative culture and the ways our people come together with the goal of helping patients. The teams that are part of our REGENXBIO Manufacturing Innovation Center (RMIC) are a prime example of collaboration in action. Hear from Katie Masterson, Senior Director of Manufacturing Operations about how our manufacturing capabilities set us apart.

Yesterday, we were honored to welcome Katie Morgan and her son Andy, who lives with Duchenne, to REGENXBIO. Andy’s energy and enthusiasm, especially when sharing his hobbies and exploring our labs and manufacturing facilities, brought smiles to everyone’s faces. It was a privilege to learn about their journey with Duchenne. We ended the day with a walk to support Parent Project Muscular Dystrophy. Thank you, Katie and Andy, for spending the day with us!